Court Grants Summary Judgment in Favor of Walsh Client

October 31, 2018 in Firm News by walsh.law

On October 10, 2018, Hon. William H. Walls, U.S.D.J. granted summary judgment to New York Life Investment Management LLC (“NYLIM”) on all claims in a suit challenging the reasonableness of the fees charged by NYLIM, the investment advisor and manager to four sub-advised mutual funds,...

Richard Badolato to Receive O’Hern Award

September 26, 2018 in Firm News by walsh.law

Newark, New Jersey, September 24, 2018 –  The New Jersey State Bar Association announced that Walsh’s Richard J. Badolato will be presented with The O’Hern Award by the New Jersey Commission on Professionalism at the organization’s annual luncheon on October 11, 2018.  Named for the...

Possible Defects In California’s New Privacy Law

August 1, 2018 in Tech Law by walsh.law

By: Peter J. Pizzi The June 2018 California Consumer Privacy Act, which becomes effective in 2020, merits attention given the size and scope of the California economy and the pattern by which that state has served as a bellwether for all things digital. After all, California...

NJ Women Inmates’ Sex Abuse Case Can Move Forward

July 23, 2018 in Firm News by walsh.law

On appeal, the Appellate Division of the Superior Court of New Jersey has ruled that a case which was originally dismissed can be revived.  The case alleges that prison officials disregarded complaints in which female inmates alleged sexual and physical abuse by a prison guard...

FDA Approves First Cannabis-Derived Drug

July 6, 2018 in Marijuana Regulatory Law by walsh.law

On June 25, 2018, the FDA approved marijuana based Epidiolex, a drug targeting severe forms of epilepsy. Whereas other synthetic marijuana drugs are already on the market, Epidiolex marks the first cannabis plant derivative to receive FDA approval. Although marijuana remains a Schedule I substance...